Guided Therapeutics (GTHP) Convertible Debt (2014 - 2025)
Guided Therapeutics' (GTHP) quarterly Convertible Debt came in at $35000.0 in Q1 2025, down 96.9% year-on-year from $1.1 million in Q1 2024, and up 150.0% quarter-over-quarter from $14000.0 in Q4 2024.
Guided Therapeutics (GTHP) Convertible Debt (2014 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Convertible Debt across 12 years of filings, most recently posting $35000.0 for Q1 2025.
- Convertible Debt for Q1 2025 came in at $35000.0, down 96.9% year-over-year; the trailing twelve-month figure through Mar 2025 was $35000.0 (down 96.9% YoY), and the FY2024 annual result was $14000.0, changed N/A from the prior year.
- Convertible Debt came in at $35000.0 for Q1 2025 at Guided Therapeutics, up from $14000.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $1.1 million in Q1 2024 to a low of $14000.0 in Q4 2024.
- The 5-year median for Convertible Debt is $820000.0 (2021), against an average of $620090.9.
- Across the five-year window, Convertible Debt soared 797.06% in 2021 and plunged 96.9% in 2025, its largest moves.
- Guided Therapeutics' Convertible Debt stood at $820000.0 in 2021, then climbed by 27.56% to $1.0 million in 2022, then declined by 6.12% to $982000.0 in 2023, then tumbled by 98.57% to $14000.0 in 2024, then jumped by 150.0% to $35000.0 in 2025.
- The last three Convertible Debt figures came in at $35000.0 (Q1 2025), $14000.0 (Q4 2024), and $162000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2023 | 982,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Jun 30, 2022 | 786,000.00 |
| Mar 31, 2022 | 852,000.00 |
| Dec 31, 2021 | 820,000.00 |
| Mar 31, 2021 | 915,000.00 |
| Dec 31, 2020 | 161,000.00 |
| Sep 30, 2020 | 622,000.00 |
| Jun 30, 2020 | 525,000.00 |
| Mar 31, 2020 | 102,000.00 |
| Dec 31, 2019 | 512.72 Mn |
| Sep 30, 2019 | 497,000.00 |
| Jun 30, 2019 | 520,000.00 |
| Mar 31, 2019 | 445,000.00 |
| Dec 31, 2018 | 380,000.00 |